Silhouette

Jeffrey D Neighbors

Terpenoid Therapeutics, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Targeting the chondrosarcoma extracellular matrix for drug delivery
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $223K 05/01/14 04/30/15
Feasibility study of GGDPS inhibition for osteoporosis
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $163K 09/01/13 08/31/14
Developing Schweinfurthin Analogs as Glioma Therapies
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 2 $339K 09/15/10 09/14/12
Schweinfurthins: novel treatment for breast cancer
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $204K 08/11/10 07/31/12
Developing Schweinfurthin Analogs as Glioma Therapies
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 2 $113K 09/22/09 09/14/10
Developing Schweinfurthin Analogs as Glioma Therapies
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 2 $332K 09/22/09 09/14/10
Improving the Distribution of Geranylgeranyl Diphosphate synthase inhibitors.
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $115K 04/06/09 03/31/11
Preclinical Development of Geranylgeranyl Disphosphate Synthase Inhibitors as Ant
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $123K 09/24/07 08/31/09
Novel Glioblastoma Therapeutics
Terpenoid Therapeutics, Inc.
Principal Investigator
HHS 1 $110K 09/15/07 09/14/09